Business Standard

Covid-19 vaccine shortages hit 60 poor countries in 'shocking imbalance'

Shortage stems mostly from India's decision to stop exporting vaccines from its Serum Institute factory, which produces the overwhelming majority of the AstraZeneca doses.

A woman at Kenyatta National Hospital in Nairobi, Kenya, receives a dose of AstraZeneca COVID-19 vaccine manufactured by SII and provided through the global COVAX initiative. (AP Photo/Brian Inganga, File)
Premium

A woman at Kenyatta National Hospital in Nairobi, Kenya, receives a dose of AstraZeneca COVID-19 vaccine manufactured by SII and provided through the global COVAX initiative. (AP Photo/Brian Inganga, File)

Lori Hinnant and Maria Cheng, Associated Press | PTI
As many as 60 countries, including some of the world’s poorest, might be stalled at the first shots of their coronavirus vaccinations because nearly all deliveries through the global program intended to help them are blocked until as late as June.

COVAX, the global initiative to provide vaccines to countries lacking the clout to negotiate for scarce supplies on their own, has in the past week shipped more than 25,000 doses to low-income countries only twice on any given day. Deliveries have all but halted since Monday.

During the past two weeks, according to data compiled daily by UNICEF, fewer

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in